Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis

A combination of 1.0mg dl-norgestrel and 0.1mg ethinylestradiol was administered orally at 18 hours after the detection of luteinizing hormone rise and again at 30 hours in five healthy volunteers with normal menstrual cycles. The effects on ovarian function were studied by comparing the daily serum...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Fertility and sterility 1983-11, Vol.40 (5), p.631-636
Hauptverfasser: Ling, William Y., Wrixon, William, Acorn, Tanya, Wilson, Elaine, Collins, John
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 636
container_issue 5
container_start_page 631
container_title Fertility and sterility
container_volume 40
creator Ling, William Y.
Wrixon, William
Acorn, Tanya
Wilson, Elaine
Collins, John
description A combination of 1.0mg dl-norgestrel and 0.1mg ethinylestradiol was administered orally at 18 hours after the detection of luteinizing hormone rise and again at 30 hours in five healthy volunteers with normal menstrual cycles. The effects on ovarian function were studied by comparing the daily serum levels of progesterone (P), 17α-hydroxyprogesterone, and estradiol (E2) measured in a control (placebo) cycle with those in two consecutive treatment cycles. Treatment did not alter the steroid levels in one subject. P was suppressed in one or both treatment cycles of four subjects. E2 was suppressed in both treatment cycles of one subject and produced widely fluctuating patterns in another. The hormonal patterns in the two consecutive treatment cycles of the same individual were similar in all but one instance, where only the P level in the second treatment cycle was diminished. These results showed that this treatment can elicit steroidogenic responses of varying degrees and duration. The contraceptive action may lie in the altered P and/or E2 level at certain points in the menstrual cycle.
doi_str_mv 10.1016/S0015-0282(16)47422-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80704628</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0015028216474224</els_id><sourcerecordid>80704628</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3514-fff426df5f1d9024f601aa14df5fbab63d3058d40157c1d1bf4b755c4a001e6a3</originalsourceid><addsrcrecordid>eNqFUcGO0zAQjRBoKQufsJIPCMEhxU5sJ3tCq9UClRZxAM6WY49bI8cOdlJUfpGfwm6rXjnZM-_Nm9F7VXVD8Jpgwt9_w5iwGjd985bwd7SjTVPTJ9WKMMZrxln7tFpdKM-rFyn9xBhz0jVX1RXnTd_hblX9_RI0oGCQVLMNvvy0q32IW0hzBIek1wjmnfUHVzpS2-CQCuNgvTxOWI-mkGYV7CwL4jNJwVSwNdpsNmv0YAyouUhPEcJ-cXIO8YCkHq23RfOoY4Jz4bf1WzTvALllhoz-KfUuxDF4QGnJV6Fy5F5GKz1KM8RgddiCh2TTy-qZkS7Bq_N7Xf34-PD9_nP9-PXT5v7usVYtI7Q2xtCGa8MM0be4oYZjIiWhpTPIgbe6xazXNHvXKaLJYOjQMaaozHYCl-119eakO8Xwa8muiNEmBc5JD2FJoscdptngTGQnooohpQhGTNGOMh4EwaKEKI4hipKQyNUxREHz3M15wTKMoC9T59Qy_vqMy6SkM1F6ZdOFdstww3uWaR9ONMhm7C1EkZQFr0DbmAMROtj_HPIPCVC_eg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80704628</pqid></control><display><type>article</type><title>Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Ling, William Y. ; Wrixon, William ; Acorn, Tanya ; Wilson, Elaine ; Collins, John</creator><creatorcontrib>Ling, William Y. ; Wrixon, William ; Acorn, Tanya ; Wilson, Elaine ; Collins, John</creatorcontrib><description>A combination of 1.0mg dl-norgestrel and 0.1mg ethinylestradiol was administered orally at 18 hours after the detection of luteinizing hormone rise and again at 30 hours in five healthy volunteers with normal menstrual cycles. The effects on ovarian function were studied by comparing the daily serum levels of progesterone (P), 17α-hydroxyprogesterone, and estradiol (E2) measured in a control (placebo) cycle with those in two consecutive treatment cycles. Treatment did not alter the steroid levels in one subject. P was suppressed in one or both treatment cycles of four subjects. E2 was suppressed in both treatment cycles of one subject and produced widely fluctuating patterns in another. The hormonal patterns in the two consecutive treatment cycles of the same individual were similar in all but one instance, where only the P level in the second treatment cycle was diminished. These results showed that this treatment can elicit steroidogenic responses of varying degrees and duration. The contraceptive action may lie in the altered P and/or E2 level at certain points in the menstrual cycle.</description><identifier>ISSN: 0015-0282</identifier><identifier>EISSN: 1556-5653</identifier><identifier>DOI: 10.1016/S0015-0282(16)47422-4</identifier><identifier>PMID: 6628707</identifier><identifier>CODEN: FESTAS</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>17-alpha-Hydroxyprogesterone ; Adult ; Biological and medical sciences ; Birth control ; Contraceptives, Postcoital - pharmacology ; Drug Combinations ; Estradiol - blood ; Ethinyl Estradiol - pharmacology ; Female ; Gynecology. Andrology. Obstetrics ; Hormonal contraception ; Humans ; Hydroxyprogesterones - blood ; Luteinizing Hormone - blood ; Medical sciences ; Norgestrel - pharmacology ; Ovary - metabolism ; Ovulation ; Population ; Time Factors</subject><ispartof>Fertility and sterility, 1983-11, Vol.40 (5), p.631-636</ispartof><rights>1983 American Society for Reproductive Medicine</rights><rights>1984 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3514-fff426df5f1d9024f601aa14df5fbab63d3058d40157c1d1bf4b755c4a001e6a3</citedby><cites>FETCH-LOGICAL-c3514-fff426df5f1d9024f601aa14df5fbab63d3058d40157c1d1bf4b755c4a001e6a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0015028216474224$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=9502685$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6628707$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ling, William Y.</creatorcontrib><creatorcontrib>Wrixon, William</creatorcontrib><creatorcontrib>Acorn, Tanya</creatorcontrib><creatorcontrib>Wilson, Elaine</creatorcontrib><creatorcontrib>Collins, John</creatorcontrib><title>Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis</title><title>Fertility and sterility</title><addtitle>Fertil Steril</addtitle><description>A combination of 1.0mg dl-norgestrel and 0.1mg ethinylestradiol was administered orally at 18 hours after the detection of luteinizing hormone rise and again at 30 hours in five healthy volunteers with normal menstrual cycles. The effects on ovarian function were studied by comparing the daily serum levels of progesterone (P), 17α-hydroxyprogesterone, and estradiol (E2) measured in a control (placebo) cycle with those in two consecutive treatment cycles. Treatment did not alter the steroid levels in one subject. P was suppressed in one or both treatment cycles of four subjects. E2 was suppressed in both treatment cycles of one subject and produced widely fluctuating patterns in another. The hormonal patterns in the two consecutive treatment cycles of the same individual were similar in all but one instance, where only the P level in the second treatment cycle was diminished. These results showed that this treatment can elicit steroidogenic responses of varying degrees and duration. The contraceptive action may lie in the altered P and/or E2 level at certain points in the menstrual cycle.</description><subject>17-alpha-Hydroxyprogesterone</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Birth control</subject><subject>Contraceptives, Postcoital - pharmacology</subject><subject>Drug Combinations</subject><subject>Estradiol - blood</subject><subject>Ethinyl Estradiol - pharmacology</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Hormonal contraception</subject><subject>Humans</subject><subject>Hydroxyprogesterones - blood</subject><subject>Luteinizing Hormone - blood</subject><subject>Medical sciences</subject><subject>Norgestrel - pharmacology</subject><subject>Ovary - metabolism</subject><subject>Ovulation</subject><subject>Population</subject><subject>Time Factors</subject><issn>0015-0282</issn><issn>1556-5653</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUcGO0zAQjRBoKQufsJIPCMEhxU5sJ3tCq9UClRZxAM6WY49bI8cOdlJUfpGfwm6rXjnZM-_Nm9F7VXVD8Jpgwt9_w5iwGjd985bwd7SjTVPTJ9WKMMZrxln7tFpdKM-rFyn9xBhz0jVX1RXnTd_hblX9_RI0oGCQVLMNvvy0q32IW0hzBIek1wjmnfUHVzpS2-CQCuNgvTxOWI-mkGYV7CwL4jNJwVSwNdpsNmv0YAyouUhPEcJ-cXIO8YCkHq23RfOoY4Jz4bf1WzTvALllhoz-KfUuxDF4QGnJV6Fy5F5GKz1KM8RgddiCh2TTy-qZkS7Bq_N7Xf34-PD9_nP9-PXT5v7usVYtI7Q2xtCGa8MM0be4oYZjIiWhpTPIgbe6xazXNHvXKaLJYOjQMaaozHYCl-119eakO8Xwa8muiNEmBc5JD2FJoscdptngTGQnooohpQhGTNGOMh4EwaKEKI4hipKQyNUxREHz3M15wTKMoC9T59Qy_vqMy6SkM1F6ZdOFdstww3uWaR9ONMhm7C1EkZQFr0DbmAMROtj_HPIPCVC_eg</recordid><startdate>198311</startdate><enddate>198311</enddate><creator>Ling, William Y.</creator><creator>Wrixon, William</creator><creator>Acorn, Tanya</creator><creator>Wilson, Elaine</creator><creator>Collins, John</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198311</creationdate><title>Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis</title><author>Ling, William Y. ; Wrixon, William ; Acorn, Tanya ; Wilson, Elaine ; Collins, John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3514-fff426df5f1d9024f601aa14df5fbab63d3058d40157c1d1bf4b755c4a001e6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>17-alpha-Hydroxyprogesterone</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Birth control</topic><topic>Contraceptives, Postcoital - pharmacology</topic><topic>Drug Combinations</topic><topic>Estradiol - blood</topic><topic>Ethinyl Estradiol - pharmacology</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Hormonal contraception</topic><topic>Humans</topic><topic>Hydroxyprogesterones - blood</topic><topic>Luteinizing Hormone - blood</topic><topic>Medical sciences</topic><topic>Norgestrel - pharmacology</topic><topic>Ovary - metabolism</topic><topic>Ovulation</topic><topic>Population</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ling, William Y.</creatorcontrib><creatorcontrib>Wrixon, William</creatorcontrib><creatorcontrib>Acorn, Tanya</creatorcontrib><creatorcontrib>Wilson, Elaine</creatorcontrib><creatorcontrib>Collins, John</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Fertility and sterility</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ling, William Y.</au><au>Wrixon, William</au><au>Acorn, Tanya</au><au>Wilson, Elaine</au><au>Collins, John</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis</atitle><jtitle>Fertility and sterility</jtitle><addtitle>Fertil Steril</addtitle><date>1983-11</date><risdate>1983</risdate><volume>40</volume><issue>5</issue><spage>631</spage><epage>636</epage><pages>631-636</pages><issn>0015-0282</issn><eissn>1556-5653</eissn><coden>FESTAS</coden><abstract>A combination of 1.0mg dl-norgestrel and 0.1mg ethinylestradiol was administered orally at 18 hours after the detection of luteinizing hormone rise and again at 30 hours in five healthy volunteers with normal menstrual cycles. The effects on ovarian function were studied by comparing the daily serum levels of progesterone (P), 17α-hydroxyprogesterone, and estradiol (E2) measured in a control (placebo) cycle with those in two consecutive treatment cycles. Treatment did not alter the steroid levels in one subject. P was suppressed in one or both treatment cycles of four subjects. E2 was suppressed in both treatment cycles of one subject and produced widely fluctuating patterns in another. The hormonal patterns in the two consecutive treatment cycles of the same individual were similar in all but one instance, where only the P level in the second treatment cycle was diminished. These results showed that this treatment can elicit steroidogenic responses of varying degrees and duration. The contraceptive action may lie in the altered P and/or E2 level at certain points in the menstrual cycle.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>6628707</pmid><doi>10.1016/S0015-0282(16)47422-4</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0015-0282
ispartof Fertility and sterility, 1983-11, Vol.40 (5), p.631-636
issn 0015-0282
1556-5653
language eng
recordid cdi_proquest_miscellaneous_80704628
source MEDLINE; ScienceDirect Journals (5 years ago - present); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects 17-alpha-Hydroxyprogesterone
Adult
Biological and medical sciences
Birth control
Contraceptives, Postcoital - pharmacology
Drug Combinations
Estradiol - blood
Ethinyl Estradiol - pharmacology
Female
Gynecology. Andrology. Obstetrics
Hormonal contraception
Humans
Hydroxyprogesterones - blood
Luteinizing Hormone - blood
Medical sciences
Norgestrel - pharmacology
Ovary - metabolism
Ovulation
Population
Time Factors
title Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T20%3A29%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mode%20of%20action%20of%20dl-norgestrel%20and%20ethinylestradiol%20combination%20in%20postcoital%20contraception.%20III.%20Effect%20of%20preovulatory%20administration%20following%20the%20luteinizing%20hormone%20surge%20on%20ovarian%20steroidogenesis&rft.jtitle=Fertility%20and%20sterility&rft.au=Ling,%20William%20Y.&rft.date=1983-11&rft.volume=40&rft.issue=5&rft.spage=631&rft.epage=636&rft.pages=631-636&rft.issn=0015-0282&rft.eissn=1556-5653&rft.coden=FESTAS&rft_id=info:doi/10.1016/S0015-0282(16)47422-4&rft_dat=%3Cproquest_cross%3E80704628%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80704628&rft_id=info:pmid/6628707&rft_els_id=S0015028216474224&rfr_iscdi=true